Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1994 1
1995 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

2 results

Results by year

Citations

1 article found by citation matching

Search results

Filters applied: . Clear all
Page 1
Polar agents with differentiation inducing capacity potentiate tumor necrosis factor-mediated cytotoxicity in human myeloid cell lines.
Depraetere S, Vanhaesebroeck B, Fiers W, Willems J, Joniau M. Depraetere S, et al. J Leukoc Biol. 1995 Jan;57(1):141-51. doi: 10.1002/jlb.57.1.141. J Leukoc Biol. 1995. PMID: 7829967
Cotreatment or pretreatment of several human myeloid cell lines (KG1, HL60, U937, THP1) with the differentiation inducer DMSO was found to potentiate the antiproliferative and cytotoxic effects of TNF. ...DMSO-induced
Cotreatment or pretreatment of several human myeloid cell lines (KG1, HL60, U937, THP1) with the differentiat
Polar agents with differentiation-inducing capacity prime myelomonocytic cell lines to lipopolysaccharide-induced cytolysis: the role of endogenous tumor necrosis factor.
Depraetere S, Joniau M. Depraetere S, et al. Leukemia. 1994 Nov;8(11):1951-9. Leukemia. 1994. PMID: 7967741
Treatment of the human myelomonocytic U937 and THP1 cell lines for 24 h with 180 mM of the differentiation inducer DMSO, resulted in priming these cells to subsequent LPS-induced cytolysis. ...Thus, DMSO-pretreated myelomonocytic …
Treatment of the human myelomonocytic U937 and THP1 cell lines for 24 h with 180 mM of the differentiation in